Subscribe To
Trending tickers: at&t, merck-daiichi sankyo, klaviyo: trending tickers october 29, 2023
Scotiabank analysts upgrade AT&T (T) stock from "Sector Perform" to "Sector Outperform." Merck (MRK) strikes a deal worth up to $22 billion with Japan...
October 20, 2023, 5:44 pm
Daiichi sankyo and merck team up on $22 bln collaboration for sankyo's antibody drug conjugates
Daiichi Sankyo and Merck have entered into an agreement worth up to $22 billion for three of Daiichi Sankyo's DXd ...
October 19, 2023, 7:46 pm
Cytomx therapeutics presents preclinical profile of epcam-directed antibody drug conjugate cx-2051 at 2023 world adc conference
– CX-2051 is tailored for treatment of EpCAM-expressing cancers by matching target expression and tumor sensitivity with a topoisomerase-1 inhibitor...
October 18, 2023, 8:30 pm
Eli lilly gets fda complete response letter for skin treatment after inspection of third-party facility
Eli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for moderate...
October 2, 2023, 6:59 am
Immunogen: takeda swoops for slice of elahere - adding to valuation uncertainty?
Yesterday, ImmunoGen, Inc. announced it has entered an exclusive licensing agreement with Takeda for the rights to develop and commercialize Mirvetuxi...
August 29, 2023, 1:45 pm
Biogen and alzheimer's disease: too early to celebrate
The FDA has granted full approval to Biogen and Eisai's anti-amyloid antibody drug Leqembi, but there i...
July 9, 2023, 11:52 pm
New results from phase 2 trial confirm benefit of trilaciclib in reducing adverse events related to an antibody drug conjugate (adc)
– On-Target Effect of Trilaciclib Reduces Rates of Multiple Adverse Events Associated with Sacituzumab Govitecan-Hziy by Over 50% Including Neutrope...
May 10, 2023, 11:31 am
Fda committee backs roche's lymphoma treatment
A U.S. Food and Drug Administration committee voted in favor of Roche Holding AG's Polivy antibody drug...
March 10, 2023, 2:10 am
Immunome: clinical data with a covid therapeutic and the abbvie collaboration
Topline data from Immunome's phase 1b trial of its COVID antibody drug, IMM-BCP-01, have led the compan...
January 31, 2023, 2:48 am
Regeneron ceo on the prospects for its eye drug eylea
CNBC's Meg Tirrell sits down with Regeneron CEO Len Schleifer to discuss the company's future, next-gen COVID ...
January 10, 2023, 11:55 am
Vincerx pharma presents preclinical data on vip943 in acute myeloid leukemia models at the 64th american society of hematology annual meeting 2022
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conj...
December 11, 2022, 3:05 pm
Vir biotech ceo on its positive covid antibody drug results
CNBC's Meg Tirrell discusses VIR Biotechnology's antibody drug results and what it can do to aid the Co...
November 19, 2022, 9:36 am
Pyxis oncology to present at h.c. wainwright preclinical cancer drug discovery conference
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation the...
June 28, 2022, 6:35 am
Lilly's antibody receives fda emergency use nod for mild-to-moderate covid-19
The FDA on Friday authorized Eli Lilly And Co's (NYSE: LLY) COVID-19 antibody drug for people aged 1...
February 14, 2022, 6:31 am
Lilly's antibody receives fda emergency use nod for mild-to-moderate covid-19
The FDA on Friday authorized Eli Lilly And Co's (NYSE: LLY) COVID-19 antibody drug for people aged 1...
February 14, 2022, 6:31 am
Lilly's antibody receives fda emergency use nod for mild-to-moderate covid-19
The FDA on Friday authorized Eli Lilly And Co's (NYSE: LLY) COVID-19 antibody drug for people aged 1...
February 14, 2022, 6:31 am
Gsk's covid-related sales close to $2 billion, profit boost to wane in 2022
GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug...
February 9, 2022, 2:27 am
Gsk's covid-related sales close to $2 billion, profit boost to wane in 2022
GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug...
February 9, 2022, 2:27 am
Gsk's covid-related sales close to $2 billion, profit boost to wane in 2022
GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug...
February 9, 2022, 2:27 am
Gsk, vir ramping up u.s. output of covid antibody drug
GlaxoSmithKline and U.S. partner Vir Biotechnology will boost production of their antibody-based COVID-19 treatment by adding a second manufacturing p...
January 21, 2022, 12:23 pm